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In 103 patients who underwent placement of 106 per-
cutaneous wire-guided intraaortic balloon catheters be-
tween August 1983 and January 1986, all placements
were successful and the average duration of counter-
pulsation was 3.4 ± 1.6 days. During counterpulsation,
45 patients developed limb ischemia that required pre-
mature balloon removal in 29 patients. The development
of limb ischemia was significantly related to the presence
of diabetes (risk ratio 2.0), peripheral vascular disease
(risk ratio 1.9), female gender (risk ratio 1.8) and the
presence of a postinsertion ankle-brachial pressure index
<0.8 (risk ratio 7.9). There was no association between
the development of limb ischemia and age, body surface
area, balloon size (10.5F/12F) or adequacy of antico-
agulation. Fifteen patients underwent vascular surgery
Intraaortic balloon counterpulsation has been available for
the hemodynamic support of critically ill patients for more
than 20 years ( I). Whereas introduction of the balloon cath-
eter initially required surgical entry of the femoral artery
and placement of an end to side prosthetic graft (2-6), a
series of technologic advances since 1980 have permitted
percutaneous insertion of an intraaortic balloon catheter
(7-13), and later percutaneous insertion over a guide wire
(14,15). More recently, smaller diameter (l0.5F [3.5 mm]
versus 12F 14.0 mm]) wire-guided balloon catheters have
become available. The incidence of balloon-related vascular
complications, however, appears to have remained quite
high; vascular complications have been reported in 9 to 36%
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for treatment of balloon-related limb ischemia, which
was associated with one operative death. Nine patients
had persistent limb ischemia (seven asymptomatic, two
symptomatic) at the time of hospital discharge.
Improvements in wire-guided balloon technology have
increased the probability of successful balloon placement
over that of surgical placement and have reduced the
incidence of major aortic injury, but there is no evidence
that these improvements have reduced the incidence of
limb ischemia or its sequelae. This should be borne in
mind before proceeding with balloon insertion in pa-
tients with one or more risk factors for developing limb
ischemia.
(J Am Coil CardioI1987;9:524-30)
and long-term sequelae in up to 7% of patients undergoing
counterpulsation (2-16).
The purpose of this study was to examine prospectively
our experience with percutaneous wire-guided intraaortic
balloon catheter insertion over the past 2112 years to define
those factors that predict vascular complications and to de-
velop strategies for the management of patients who develop
limb ischemia during counterpulsation.
Methods
Patient characteristics. The study group consisted of
103 patients undergoing 106 consecutive percutaneous in-
traaortic balloon insertions during the 30 months between
August 1983 and January 1986. The average age was
63 ± II years. Seventy-three patients were male and 33 were
female. Twenty-one patients had diabetes and 22 had evi-
dence of peripheral vascular disease by history (claudica-
tion, prior vascular procedure), physical examination (bruits,
decreased distal pulse amplitude) or laboratory evaluation
(angiography. noninvasive testing).
0735-1097/87/$3.50
lACC Vol. 9, No.3
March 19X7:524-30
ALDERMAN ET AL.
VASCULAR COMPLICATIONS 'OF THE INTRAAORTIC BALLOON
525
The primary indications for balloon insertion are sum-
marized in Table 1. Overall, 80% of patients underwent
intraaortic balloon placement primarily for relief of isch-
emia, and 20% for stabilization of hemodynamic instability
(which included cardiogenic shock in 16% of patients),
Technique of insertion. The intraaortic balloon catheter
was wrapped according to the manufacturer's recommen-
dations and placed into the femoral artery through an arterial
sheath and over an 0,032 inch (0,8 mm) or 0,035 inch (0,9
mm) guide wire previously positioned in the descending
aorta, In 91% of cases, insertion was performed under flu-
oroscopic visualization, Intraoperative insertions did not
employ fluoroscopy, but correct balloon position was
confirmed by chest X-ray film,
The 12F balloon catheter manufactured by Kontron In-
struments was used predominantly in the first half of the
study period (50 patients), whereas the 1O,5F balloon cath-
eter manufactured by Datascope Corporation was used pre-
dominantly in the second half of the study period (48 pa-
tients), By micrometer measurement (MG Tool Co.), the
12F Kontron sheath has an outer diameter of 4.57 mm, and
the 10.5F Datascope sheath has an outer diameter of 4.17
mm-a net difference of only 0.4 mm. Each patient received
a 5,000 unit intravenous bolus injection of heparin at the
time of balloon insertion, and was then placed on a contin-
uous intravenous heparin infusion with the goal of main-
taining a partial thromboplastin time of 1.5 times the control
value on at least 90% of the determinations made during
the period of counterpulsation.
Patient follow-up. After balloon insertion, patients were
followed up by cardiology and vascular surgical staff. who
performed a daily vascular examination and determined the
"ankle-brachial index." This index is the ratio of the sys-
tolic, Doppler-derived dorsalis pedis or posterior tibial ar-
terial pressure to the simultaneous systolic, Doppler-derived
brachial arterial pressure (normal value 0.8 to 1.2).
Data collection. The following variables were evalu-
ated: demographic and clinical data, methodologic details
of balloon insertion and removal, adequacy of anticoagu-
lation, development of clinical limb ischemia, ankle-bra-
Table l. Primary Indication for Balloon Insertion
Indication
Ischemia
Unstable angina
Instability at catheterization
Severe left main coronary disease
Angioplasty complication
Elective preoperative placement
Hemodynamic instability
Myocardial infarction
Ventricular septal defect
Mitral regurgitation
Postoperative stabilization
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Figure l. Life table analysis showing the percentof patients free
of limb ischemia versus days of intraaortic balloon counterpul-
sation (post-IABP).
chial pressure index, duration of balloon counterpulsation,
balloon-related complications, balloon-related vascular sur-
gery, operative findings and vascular status at hospital dis-
charge. Clinical limb ischemia was defined as a development
of unilateral pulse diminution accompanied by abnormal
limb temperature, color, motor function, pain or pares-
thesia.
Statistical analysis. Statistical evaluation was per-
formed to identify potential predictors of clinical limb isch-
emia and subsequent vascular surgery. All variables were
analyzed using univariate (chi square and Fisher's exact
tests) and stepwise multivariate analysis, with significance
taken at the probability (p) value of <0.05. For each variable
significantly related to limb ischemia, a risk ratio was cal-
culated as the probability of ischemia given the presence of
the variable, divided by the probability of ischemia given
the absence of that variable (17). Risk ratios above 1.0 thus
correspond to the relative increase in the risk of developing
limb ischemia if that variable is present. Life table analysis
was used to compute the incidence of limb ischemia as a
function of duration of counterpulsation.
Results
Balloon placement. Of the 106 consecutive attempts in
the 103 patients, placement problems were encountered in
18 patients (17%). In 12 of these patients, placement dif-
ficulty was the result of iliac artery tortuosity or stenosis.
All attempts at insertion, however, were ultimately suc-
cessful. The mean duration of balloon counterpulsation was
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3.4 ± 1.6 days (range 1 to lo). Eighty-three (81%) of the
patients underwent subsequent cardiac surgery, and 87 pa-
tients (84%) survived to hospital discharge. Adequate an-
ticoagulation was achieved in 60% of the patients.
Development of limb ischemia. Clinically apparent limb
ischemia was noted after 45 (42%) of the 106 balloon place-
ments (43% of patients). In addition to diminished distal
pulses in the limb with balloon insertion, concomitant find-
ings of ischemia included abnormal limb temperature in 36
(80%), abnormal limb color in 25 (62%), abnormal motor
function in 4 (9%), limb pain in 8 (18%) and limb pares-
thesia in lo (24%). Findings of limb ischemia were suffi-
ciently severe so as to initiate premature discontinuation of
intraaortic balloon counterpulsation (primary indication for
balloon removal given as "limb ischemia") in 29 patients
(27%).
Limb ischemia was usually evident during the first day
of counterpulsation. but life table analysis (Fig. 1) showed
that additional patients continued to develop limb ischemia
as the duration of balloon counterpulsation increased. Thus,
whereas 68% of patients were free of limb ischemia on day
1, only 48% remained ischemia-free by day 4. There was,
however, no further incidence of limb ischemia among the
16patients who required 5 or more days of counterpulsation.
Other complications (aortic dissection or perforation, fever,
arterial embolic phenomena) seen in prior series of surgical
and nonwire-guided percutaneous balloon placement were
absent.
Univariate and multivariate analyses were applied to
identify significant predictors of limb ischemia. Three pre-
balloon insertion variables were found to be significantly
related to the development oflimb ischemia (Table 2). These
variables were female gender, presence of diabetes and pres-
ence of peripheral vascular disease, with calculated relative
risk ratios of 1.8,2.0 and 1.9, respectively. Only two post-
balloon placement variables were significantly related to the
development of limb ischemia: an initial postplacement an-
kle-brachial pressure index of <0.8 (present in 39% of
patients) or the occurrence of an ankle-brachial index of
<0.8 at any time during balloon counterpulsation, associ-
Table 2. Predictors of Limb Ischemia in 106 Attempted Balloon Catheter Insertions
Total No. Patients Developing Relative Univariate
of Patients Limb Ischemia Risk Ratio p Value
Preinsertion variables
Diabetes
Yes 21 15 (71%) 2.0 <0.002*
No 85 30 (35%)
PYD
Yes 22 15 (68%) 1.9 <0.006*
No 84 30 (36%)
Sex
Female 33 20 (61%) 1.8 <0.01*
Male 73 25 (35%)
Shock
Yes 17 6 (35%) NS
No 89 39 (44%)
Age
>65 50 25 (50%) NS
<65 56 20 (36%)
Body surface area NS
Postinsertion variables
Initial ABI
1.1 to 1.2 14 4 (29%)
0.8 to 1.0 33 8 (24%) 3.1 <0.003*0.6 to 0.7 18 12 (67%)
<0.6 12 12 (100%)
ABI ever <0.8
Yes 43 35 (81%) 7.9 <0.001 *
No 39 4 (10%)
Adequate anticoagulation
Yes 56 25 (45%) NS
No 38 18 (49%)
IABP type
Kontron (I2F) 50 22 (44%) NS
Datascope (l0.5F) 48 21 (44%)
*Denotes p < 0.005 by multivariate analysis. ABI = ankle-brachial pressure index; IABP = intraaortic
balloon pump; PYD = peripheral vascular disease.
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ated with a risk ratio of 3, I and 7,9, respectively, The
presence of cardiogenic shock, age or body surface area
( I. 8 ± 2.5 rrr' with ischemia/I.9 ± 0.2 rrr' without isch-
emia) was not a significant predictor of balloon-related isch-
emia. Similarly, neither intraaortic balloon size or type nor
the adequacy of anticoagulation influenced the occurrence
of ischemia during counterpulsation.
Management of limb ischemia. If the intraaortic bal-
loon has been placed for appropriate indications and is pro-
viding needed clinical benefit, its premature removal to con-
trol balloon-related limb ischemia may pose a significant
management problem, Among the 29 patients with such
premature removal, balloon placement had been performed
for control of myocardial ischemia in 25 and for control of
hemodynamic instability in 4. Seven patients had the balloon
removed before cardiac surgery: one patient required im-
mediate placement of a new balloon in the opposite leg,
whereas a second patient required urgent coronary bypass
surgery within 12 hours for ongoing instability (both of these
patients subsequently required vascular surgery); five pa-
tients did not have cardiac surgery after balloon removal
(because of spontaneous improvement in two patients and
supervening clinical complications in three), Four patients
with limb ischemia had the balloon removed at the time of
Table 3. Predictors of Vascular Surgery Among 45 Patients With Limb Ischemia
NS
9.6 <0.05
NS
NS
9.0 <0.03*
NS
Patients
Undergoing
Total No. Vascular
of Patients Surgery
Preinsertion variables
Age
>65 25 7 (28%)
<65 20 8 (40%)
Sex
Female 20 5 (25%)
Male 25 10 (40%)
Diabetes
Yes 15 4 (26%)
No 30 II (37%)
PVD
Yes 15 3 (29%)
No 30 12 (40%)
Shock
Yes 6 2 (33%)
No 39 13 (33%)
Postinsertion variables
IABP type
Kontron (l2F) 22 6 (27%)
Datascope (I0.SF) 21 8 (38%)
Adequate anticoagulation
Yes 25 8 (32%)
No 18 7 (39%)
Initial ABI
1.1 to 1.2 4 3 (75%)
0.8 to 1.0 8 0(0%)
0.6 to 0.7 12 5 (42%)
<0.6 12 3 (25%)
ABI ever <0.8
Yes 35 12 (34%)
No 4 0(0%)
Symptoms/signs of
ischemia
Pain 8 4 (50%)
Paresthesia II 8 (73%)
Abnormal temperature 36 14 (39%)
Abnormal color 28 11(39%)
Abnormal motor 4 4 (100%)
function
Diminished distal pulses 43 15 (31%)
Relative
Risk Ratio
Univariate
p Value
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
*p < 0.05 by multivariate analysis. Abbreviations as in Table 2.
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cardiac surgery (the timing of which was accelerated be-
cause of ongoing limb ischemia), with concurrent vascular
exploration in three patients (one showed an obstructing
plaque, and two had no evident disease). Eighteen patients
with limb ischemia had the balloon removed after cardiac
surgery, the timing of which had been accelerated in I
patient; the presence of postoperative limb ischemia accel-
erated the balloon weaning process in the remaining 17
patients. Six of these 18 patients required subsequent vas-
cular surgery.
Overall. limb ischemia resolved in 30 of the 45 patients
after balloon removal alone; the 15 remaining patients
underwent vascular surgery. In 10 of these 15 patients,
vascular surgery was performed for persistent ischemia after
balloon removal, whereas the remaining 5 patients under-
went combined intraoperative balloon removal and vascular
repair as treatment for profound limb ischemia. Operative
findings included thrombus adjacent to the puncture site or
in a distal vessel (eight patients), intimal dissection (one
patient) and arterial compression by hematoma (one pa-
tient). None of the five patients undergoing intraoperative
balloon removal, however, exhibited vascular disease be-
yond simple luminal obstruction by the balloon shaft. Among
the 45 patients manifesting limb ischemia, the only factors
predictive of the need for subsequent vascular surgery were
the development of paresthesia or abnormal motor function
during counterpulsation (Table 3).
Vascular surgical intervention included removal of the
balloon alone (five patients), thrombectomy or thromboem-
bolectomy, or both (eight patients), evacuation of hematoma
(one patient) and fasciotomy for an ischemia-related com-
partment syndrome (one patient). Arterial repair usually
consisted of simple suture closure (IO patients), although a
saphenous vein patch (3 patients) or insertion of a short
segment of bypass conduit (I patient) was occasionally re-
quired.
At the time of hospital discharge. 78 (90%) of the 87
surviving patients were free of limb ischemia, but persistent
limb ischemia was present in 9 patients. This was asymp-
tomatic in seven patients (diminished pulse or ankle-brachial
index <0.08, or both) and symptomatic (claudication) in
two patients. Sixteen patients who underwent balloon coun-
terpulsation died during hospitalization, but only one of the
deaths (a complication of anesthesia during vascular sur-
gery) could be classified as a direct result of balloon coun-
terpulsation.
Discussion
Intraaortic balloon counterpulsation was developed in the
1960s to provide hemodynamic stabilization in critically ill
patients (I). The initial balloon catheters were inserted sur-
gically by way of a conduit attached to the common femoral
artery. Although therapeutically effective, this mode of bal-
loon counterpulsation was associated with a high rate of
vascular complications (2-6,11-13). The alternative of per-
cutaneous placement has evolved as the result of three major
advances: I) percutaneous placement of "surgical" balloons
by way of a femoral artery sheath (7,8), 2) development of
"double lumen" balloons to-permit placement over a central
guide wire (14), and 3) development of lower profile (l0.5F
versus 12F) wire-guided catheters.
Prior studies of balloon-related complications. Whereas
the percutaneous technique has allowed more rapid and more
convenient initiation of counterpulsation, it does not appear
to have significantly reduced the incidence of vascular com-
plications. Kantrowitz et al. (12) recently reviewed their 15
year experience with 733 patients undergoing balloon coun-
terpulsation. There was a 26% incidence rate of vascular
complications after 387 surgical balloon placements from
1974 to 1979 and a 47% incidence rate of such complications
after 232 percutaneous balloon placements from 1980 to
1982. Similar findings have now been reported by this group
in a study of 101 patients randomly assigned to percutaneous
or surgical balloon placement (13). The 22% vascular com-
plication rate for percutaneously placed balloon catheters
was significantly higher than the 4% incidence reported for
surgically placed balloons, but the two complication rates
become more equal if the additional 18% of surgical patients
who had distal clot retrieved at the time of balloon removal
are considered as having "vascular complications" rather
than normal surgical balloon removal. Whereas surgical
intervention was required in approximately 20% (12,13) of
their patients undergoing percutaneous balloon insertion,
long-term sequelae were uncommon. Other studies of per-
cutaneously placed balloon catheters (7-11,14-16) have
suggested a similar incidence of complications, but these
studies were performed chiefly with older, nonwire-guided
catheters and were performed before the availability of the
newer 1O.5F balloon catheters.
Complications in the currentstudy. Our study, which
is only the second to use exclusively wire-guided percuta-
neous balloon catheters (14) and the first to use the newer
1O.5F design, demonstrates a continued high incidence of
limb ischemia. Of 103 consecutive patients undergoing per-
cutaneous intraaortic balloon counterpulsation, 45 (43%)
developed clinically evident limb ischemia, which resulted
in premature discontinuation of counterpulsation in 29 pa-
tients. Although limb ischemia was usually relieved simply
by removal of the balloon catheter, IS patients (predomi-
nantly those with severe ischemia manifested by abnormal
limb motor function or paresthesia) required vascular sur-
gery, which was associated with one operative (anesthesia-
related) death. One patient had ongoing symptoms despite
vascular surgery (persistent weakness as the result of a com-
partment syndrome caused by prolonged limb ischemia),
two additional patients continued to have symptomatic limb
ischemia but did not undergo vascular surgery and seven
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patients had asymptomatic persistent vascular compromise.
Thus, limb ischemia was relieved in the vast majority of
patients by balloon removal. either alone or in preparation
for vascular surgical repair, so that long-term sequelae re-
lated to limb ischemia occurred in only 5% of patients.
Risk factors for limb ischemia. Prior studies have iden-
tified a group of clinical factors associated with vascular
complications. Applying multivariate analysis to patients
undergoing either percutaneous or surgical balloon inser-
tion, Gottlieb et al. (15) found that peripheral vascular dis-
ease and female gender were the only significant predictors
of vascular complications . In a more recent series, Goldberg
et al. (13) found that diabetes and hypertension, as well as
female gender, were related to the development of vascular
complications.
Our series supports the findings of prior studies in iden-
tifying female gender, diabetes and peripheral vasculardis-
ease as factors independently associated with a twofold in-
crease in the risk of developing clinical limb ischemia after
balloon insertion. The increased risk associated with female
gender did not seem to be related simply to a smaller body
surface area and body surface area did not appear to be a
significant predictorof ischemic complications in our patient
group as a whole. One additional factor. the presence of a
diminished ankle-brachial pressure index after balloon
placement, was associated with a risk ratio of 7.9 for the
development of clinical limb ischemia. Although this as-
sociation is most likely based on the fact that reduction in
the ankle-brachial index is another indicator of limb isch-
emia (along with the clinical variables mentioned) it does
suggest a potentially valuable role for using the ankle-bra-
chial index in routine monitoring of patients after balloon
placement. Age of patient, adequacy of anticoagulation and
the outer diameter of the balloon sheath (4.17 versus 4.57
mm) did not correlate with the development of limb isch-
emia. Given the incidence of limb ischemia, this suggests
that both sheath diameters are too large to be accommodated
within the femoral artery lumen of the ischemia-prone pa-
tient.
Management of balloon-related limb ischemia. Among
patients manifesting limb ischemia, only the presence of
paresthesia or abnormal motor function was associated with
the requirement for vascular surgical repair. Our experience
suggests that the initial step in the management of significant
balloon-related limb ischemia is rapid weaning from coun-
terpulsation. If this can be achieved without cardiac insta-
bility, the balloon catheter should be removed percuta-
neously at the bedside, and only those patients exhibiting
ongoing limb ischemia after balloon removal should be con-
sidered candidates for vascular surgery. Patients who de-
velop recurrent cardiac instability after weaning and balloon
removal should be taken immediately to cardiac surgery.
Those who cannot be weaned successfully should be taken
immediately to cardiac surgery with the balloon in place.
with the intent of removing it surgically once the patient
has been placed on cardiopulmonary bypass, or revising the
placement (see later) if postoperative support is required.
Because most patients in our series underwent counter-
pulsation for the control of ischemia before coronary re-
vascularization (rather than for the management of cardio-
genic shock), very few patients with limb ischemia were
balloon-dependent after cardiac surgery. In such balloon-
dependent patients, surgical placement of a small caliber
balloon or construction of a femorofemoral crossover graft
(5) may be the only way to control limb ischemia in the
face of continued requirement for counterpulsation.
Conclusions. Whereas current percutaneous wire-guided,
intraaortic balloon catheters for counterpulsation can be in-
serted in essentially all patients in whom it is attempted,
somedegreeof limb ischemia, relatedto several preinsertion
risk factors and to a low postinsertion ankle-brachial pres-
sure index. developed in 43% of 103 treated patients. Limb
ischemia led to premature discontinuation of counterpul-
sation in 27% of patients. Whereas limb ischemia usually
resolved after balloon removal alone, 14% of patients
undergoing counterpulsation required vascular surgical re-
pair. Although long-term sequelae were rare, the continued
presence of significant counterpulsation-related risks are now
considered at our institution before insertion of intraaortic
balloon catheters in high risk patients for whom prompt
coronary revascularization without counterpulsation might
be a better option. Efforts to develop new balloon catheters
capable of introduction through smaller sheaths should be
encouraged in the hope of reducing the continued unac-
ceptably high incidence of balloon-related limb ischemia
with current devices.
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